Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
光化性角化病患者的皮肤癌风险和风险预测
基本信息
- 批准号:10448977
- 负责人:
- 金额:$ 26.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-18 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:Actinic keratosisAddressAdoptedAdvisory CommitteesAffectAwardBachelor&aposs DegreeBasal cell carcinomaBehavioralBiologicalCancer CenterCaringChronicClinicalClinical ResearchCutaneous Precancerous ConditionDataData SetData SourcesDermatologyDevelopment PlansDiagnosisEarly DiagnosisEnvironmentEpidemiologyFellowshipFoundationsFrequenciesFundingFutureGeneticGoalsGuidelinesHealth Services ResearchIndividualInvestigationKnowledgeLesionMalignant - descriptorMalignant Epithelial CellMalignant NeoplasmsMeasuresMedicareMedicare claimMelanoma CellMentorsMentorshipModelingOncologyPatient CarePatientsPatternPennsylvaniaPerformancePersonsPhenotypePhysiciansPositioning AttributePostdoctoral FellowProviderRecommendationRelative RisksReportingResearchResearch Project SummariesResidenciesRiskScientistSkin CancerSquamous cell carcinomaSun ExposureTimeTrainingUV Radiation ExposureUnited StatesUnited States National Institutes of HealthUniversitiesVisitWorkanticancer researchbasebeneficiarybiobankcancer epidemiologycancer riskcareercareer developmentclinical biomarkersclinical careclinical decision-makingclinical practiceevidence baseexperiencefollow-upgenetic epidemiologygenetic informationhigh riskhigh risk populationindividual patientmedical schoolsmelanomamelanoma biomarkersmodel developmentpatient orientedpatient oriented researchprofessorresearch and developmentrisk predictionrisk prediction modelskillsskin squamous cell carcinomatooltool development
项目摘要
PROJECT SUMMARY
Research: Actinic keratoses (AKs) are pre-cancerous skin lesions that arise in the setting of chronic sun
exposure and affect tens of millions of people in the United States each year. AKs have a risk of transformation
to cutaneous squamous cell carcinoma. The majority of AK clinical care and research focuses on the individual
AK and its risk of malignant transformation. However, there is evidence that the presence of AKs may be
associated with increased risk of squamous cell carcinoma and other types of skin cancer (melanoma and
basal cell carcinoma) for the patient as a whole. Though they are not typically used this way, AKs may be an
important clinical biomarker of skin cancer risk, including melanoma, squamous cell carcinoma, and basal cell
carcinoma. Unfortunately, there are no specific recommendations for clinicians to follow for skin cancer
surveillance or early detection in patients with AKs. This project will address key knowledge gaps: to examine
the absolute risks of skin cancer in patients with AKs, which are unknown (Aim 1); to understand the care
currently being provided to patients with AKs, which is uncharacterized (Aim 2); and to develop a skin cancer
risk prediction model for patients with AKs, which has not previously been done (Aim 3). The overarching goal
is to provide evidence to guide clinical care and form the foundation for future recommendations on skin cancer
surveillance and early detection in patients with AKs, a large and high-risk group. Candidate: Dr. Mackenzie
Wehner, MD MPhil is an Assistant Professor of Health Services Research and of Dermatology at MD
Anderson Cancer Center. She completed her undergraduate degree at Yale University, medical school at
Stanford University, a Master's in Epidemiology at the University of Cambridge, and residency and post-
doctoral research fellowship at the University of Pennsylvania. Her career goal is to become an independent,
R01-funded physician scientist in patient-oriented skin cancer research and through her research to decrease
the burden of skin cancer in the United States. Environment: During this award period Dr. Wehner will devote
at least 75% of her time to research and 20% to clinical care of patients at high risk of skin cancer, including
those with AKs. Her primary mentor, Dr. Sharon Giordano, and co-mentor, Dr. David Margolis, are proven
mentors and experts in patient-oriented research in cancer. The exceptional training environment in cancer
research at MD Anderson will offer Dr. Wehner an outstanding opportunity to launch her career as an
independent physician-scientist. Career Development: Dr. Wehner will have support from an experienced and
diverse advisory committee and will focus her training on developing skills and experience in 1) health services
research and large administrative datasets, 2) risk prediction modeling and tools development, and 3)
incorporating genetic data in epidemiologic analyses. Completion of the proposed research and career
development plan will serve as a platform upon which Dr. Wehner can successfully transition to independence
and pursue an impactful career focused on patient-oriented skin cancer research.
项目概要
研究:光化性角化病 (AK) 是在长期阳光照射下出现的癌前皮肤病变
每年有数千万美国民众受到影响。 AK有转型风险
皮肤鳞状细胞癌。 AK 的大部分临床护理和研究都集中于个人
AK及其恶变风险。然而,有证据表明 AK 的存在可能是
与鳞状细胞癌和其他类型皮肤癌(黑色素瘤和
基底细胞癌)对于整个患者来说。尽管 AK 通常不以这种方式使用,但它们可能是一种
皮肤癌风险的重要临床生物标志物,包括黑色素瘤、鳞状细胞癌和基底细胞癌
癌。不幸的是,对于皮肤癌,临床医生没有可遵循的具体建议
AK 患者的监测或早期检测。该项目将解决关键的知识差距:
AK 患者患皮肤癌的绝对风险尚不清楚(目标 1);去了解护理
目前正在向 AK 患者提供,但其特征尚不明确(目标 2);并发展为皮肤癌
AK 患者的风险预测模型,此前尚未完成(目标 3)。总体目标
旨在提供指导临床护理的证据,并为未来皮肤癌的建议奠定基础
对 AK 患者(一个庞大的高危群体)进行监测和早期发现。候选人:麦肯齐博士
Wehner,医学博士 哲学硕士是医学博士健康服务研究和皮肤病学助理教授
安德森癌症中心。她在耶鲁大学医学院完成了本科学位
斯坦福大学、剑桥大学流行病学硕士学位、住院医师实习期和毕业后
宾夕法尼亚大学博士研究奖学金。她的职业目标是成为一个独立的、
R01 资助的医师科学家从事以患者为导向的皮肤癌研究,并通过她的研究减少
美国皮肤癌的负担。环境:在此颁奖期间,Wehner 博士将致力于
她至少 75% 的时间用于研究,20% 的时间用于对皮肤癌高风险患者进行临床护理,包括
那些有 AK 的人。她的主要导师 Sharon Giordano 博士和共同导师 David Margolis 博士已被证明
以患者为导向的癌症研究的导师和专家。癌症方面的特殊培训环境
MD 安德森的研究将为 Wehner 博士提供一个绝佳的机会来开启她的职业生涯
独立医师科学家。职业发展:Wehner 博士将得到经验丰富且专业的人士的支持
多元化的咨询委员会,并将重点培训她在 1) 卫生服务方面的技能和经验
研究和大型管理数据集,2) 风险预测建模和工具开发,以及 3)
将遗传数据纳入流行病学分析。完成拟议的研究和职业生涯
发展计划将成为韦纳博士成功过渡到独立的平台
并追求有影响力的职业生涯,专注于以患者为导向的皮肤癌研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mackenzie Rachel Wehner其他文献
Mackenzie Rachel Wehner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mackenzie Rachel Wehner', 18)}}的其他基金
Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
光化性角化病患者的皮肤癌风险和风险预测
- 批准号:
10610895 - 财政年份:2022
- 资助金额:
$ 26.04万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 26.04万 - 项目类别:
Research Grant














{{item.name}}会员




